key: cord-0719335-5dj21i62
authors: Mulay, Apoorva; Konda, Bindu; Garcia, Gustavo; Yao, Changfu; Beil, Stephen; Villalba, Jaquelyn Mary; Koziol, Colin; Sen, Chandani; Purkayastha, Arunima; Kolls, Jay.K.; Pociask, Derek.A.; Pessina, Patrizia; Sainz de Aja, Julio; Garcia-de-Alba, Carolina; Kim, Carla F.; Gomperts, Brigitte; Arumugaswami, Vaithilingaraja; Stripp, Barry R.
title: SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
date: 2021-04-13
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.109055
sha: 49b4106180d4a727a0dabbd9e761497192fa4a64
doc_id: 719335
cord_uid: 5dj21i62

Coronavirus disease 2019 (COVID-19) is the latest respiratory pandemic caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2). While infection initiates in the proximal airways, severe and sometimes fatal symptoms of the disease are caused by infection of the alveolar type 2 (AT2) cells of the distal lung and associated inflammation. In this study we develop primary human lung epithelial infection models to understand initial responses of proximal and distal lung epithelium to SARS-CoV-2 infection. Differentiated air-liquid interface (ALI) cultures of proximal airway epithelium and alveosphere cultures of distal lung AT2 cells are readily infected by SARS-CoV-2, leading to an epithelial cell-autonomous proinflammatory response with increased expression of interferon signaling genes. Studies to validate the efficacy of selected candidate COVID-19 drugs confirm that Remdesivir strongly suppresses viral infection/replication. We provide a relevant platform for study of COVID-19 pathobiology and for rapid drug screening against SARS-CoV-2 and emergent respiratory pathogens.

2K). Of the total HTII 280 + AT2 cells, 46% were infected by SARS-CoV-2 ( Figure 2L ). Of the 9 total infected cells, 55.09% were HTII 280 + AT2 cells ( Figure 2M ). 10

Having established a model that enables robust infection of AT2 cells by SARS-CoV-2, we 13 further evaluated the utility of this system to study host pathogen responses. Additionally, multiple downstream interferon signaling genes (ISGs) such as IF144L, IFIT1, 9 RSAD2 IRF1, IRF3, IRF7, IRF9 IF127, STAT1, JAK1, OAS1, OAS2 ISG15 and MX1 were 10 significantly upregulated in infected cultures ( Figures 3C and 3D ). These observed increases in 11 gene transcript levels were further validated by qRT-PCR ( Figure S2C ). 12

Analysis of differentially regulated canonical pathways revealed that other proinflammatory and 13 viral-sensing pathways, such as NF-kB activation, TGFβ signaling and RIG1-like receptor 14 signaling, were also up-regulated in virus-infected cells ( Figure 3E ). On the other hand, various 15 signaling pathways related to regulation of stem cell activation and fate, such as Notch, Wnt and 16 BMP signaling, were downregulated ( Figures 3B and 3E ). However, we did not observe 17 significant changes in expression of the AT2 cell markers including SFTPC, SFTPA1, SFTPA2 18 and SFTPD (Figures 3B). Furthermore, we did not observe a change in transcript levels for viral 19 entry genes such as ACE2 and TMPRSS2 ( Figure 3B ). Taken together, these data indicate that 20 SARS-CoV-2 infection induces significant upregulation of innate immune response genes in 21 alveolar cells without the participation of recruited immune cells. 22

Another key pathway that was activated in SARS-CoV2-infected alveolar cultures included the 2 protein ubiquitination pathway. In particular, we saw a significant increase in transcripts for 3 genes whose products act either as chaperons/co-chaperons or sensitize cells to apoptosis. For 4 example, we saw a significant upregulation PSMA3, DNAJC3, DNAB11 and TAP1 ( Figure 4A ), 5 all of which are typically upregulated by cellular stress and interact with key components of 6 apoptotic pathways. Furthermore, we also observed upregulation of apoptosis related genes 7 CASP6 and BCL2 in SARS-CoV-2 infected cultures ( Figure 4A ). In order to confirm increased 8 cellular apoptosis in SARS-CoV2-infected cultures, we performed immunofluorescent staining 9 of MOCK and infected cultures for the apoptotic marker, cleaved caspase 3 (CC3). By 3dpi, 10 infected cultures exhibited significantly enhanced staining for CC3 compared to mock cultures. 11

Interestingly only a proportion of the apoptotic cells were infected, thus suggesting that SARS- Further we tested the efficacy of selected potential therapeutic agents against SARS-5

CoV-2 infection of AT2 cells and found that viral infection and/or replication was strongly 6 suppressed by the candidate drug, Remdesivir. Remdesivir is currently the most promising 7 candidate drug and has been granted emergency use authorization for treatment of hospitalized For infection of proximal airway ALI cultures, 100 µl of SARS-CoV-2 virus inoculum (1x10^4 12 TCID50 per well) was added on to the apical chamber of inserts. Cells were incubated at 37°C 13 (5% CO2) for 2 hours for virus adsorption. Subsequently, the cells were washed and fresh 14

Pneumacult ALI media (500 µl in the base chamber) was added. Cells were incubated at 37°C 15 (5% CO2 and harvested for analysis at indicated time points for sample collection. 16

Proximal ALI and alveolar cultures were infected with 1x10^4 TCID50 per well of SARS-19 CoV-2 as described before. For AT2 cells, at each timepoint (1,2 and 3dpi), media from the 20 basal chamber from mock and SARS-CoV-2 infected wells were collected and stored at -80°C. 21

For ALI cultures, apical washes at each time point were collected and stored at 80°C. Viral 22 production by infected cultures was measured by quantifying TCID50 (Median Tissue Culture 1 Infectious Dose) as described(Gauger and Vincent, 2014). Breifly, Vero-E6 cells were plated in 2 96-well plates at a density of 5 x10 3 cells/well. The following day, samples collected from the 3 cultures at the different timepoints were subjected to 10-fold serial dilutions (10 -1 to 10 -6 ) and 4 inoculated onto Vero-E6 cells. The cells were incubated at 37°C with 5% CO2. After 72 5 hours, each inoculated well was examined for presence or absence of viral CPE and 6 percent infected dilutions immediately above and immediately below 50% were determined. 7 TCID50 was calculated based on the method of Reed and Muench. Appropriate secondary antibodies conjugated to fluorophores (Thermo Fisher Scientific) were 10 applied to the samples for 1 hour at room temperature. Samples were washed 3 times for 5 11 minutes each with PBS followed by addition of DAPI (1:5000) for 5 minutes. Insert membranes 12

were carefully detached from their transwell support with a fine scalpel, and transferred to a 13 glass microscopic slide. Samples were mounted using Fluoromount G (Thermo Fisher 14 Scientific), imaged on a Zeiss LSM 780 Confocal Microscope and images were processed using 15

Zen Blue software (Zeiss). 16

Total RNA was extracted from mock and SARS-CoV-2 infected proximal airway ALI and 19 alveolar cultures lysed in Trizol (Thermo Fisher Scientific) using the chloroform-iso-propanol-20 ethanol method. 500ng of RNA was reversed transcribed into cDNA in a 20 µL reaction volume 21 using iScript cDNA synthesis kit (Biorad) in accordance to manufacturer's guidelines. was performed on 10ng of CDNA per reaction in triplicates for each sample using SYBR green 23 master mix (Thermo Fisher Scientific) on a 7500 Fast Real Time PCR system (Applied 1 biosystems). Primers sequences for detection of SARS-CoV-2 N gene were obtained from the 2 Center for Disease Control's resources for research labs. Primer pairs used are described in Table  3 S1 4

SARS-CoV-2 RNA transcript levels in infected samples were quantified by comparing 6 them to a standard curve generated using serial ten-fold dilutions (10 1 -10 9 copies) of a 7 SARS-CoV-2 N gene containing plasmid. 8 9 Bulk RNA sequencing 10 2 days after SARS-CoV-2 infection, cells were lysed in RLT buffer and total RNA was extracted 11 for bulk RNA sequencing using a Qiagen RNEasy Mini Kit. RNA quality was analyzed using the 12 2100 Bioanalyzer (Agilent Technologies) and quantified using QubitTM (ThermoFisher 13 Scientific). Library construction was performed by the Cedars-Sinai Applied Genomics, 14

Computation and Translational Core using the Lexogen RiboCop rRNA Depletion kit and Swift 15

Biosciences RNA Library Sciences. Sequencing was performed using the the NovaSeq 6000 16 (Illumina) with single-end 75bp sequencing chemistry. On average, about 20 million reads were 17 generated from each sample. Raw reads were aligned using Star aligner 2.6.1 (Dobin et al., 18 

containing all 20 protein coding and long non-coding RNA genes based on human GENCODE version

Type 2 alveolar cells are stem cells in adult lung

Single cell RNA sequencing of 13 human tissues identify cell types and 1 receptors of human coronaviruses

Building and maintaining the epithelium of the 3 lung

Single-cell longitudinal analysis of SARS-CoV-2 infection in 5 human bronchial epithelial cells

Human organs-on-chips as tools for repurposing approved drugs as potential 7 influenza and COVID19 therapeutics in viral pandemics

SARS-CoV-2 entry factors are highly expressed in nasal epithelial 9 cells together with innate immune genes

The trinity of COVID-19: immunity, inflammation and intervention

Reassortment of pandemic H1N1/2009 influenza A virus in 13 swine

Remdesivir in adults with severe COVID-19: a randomised, double-15 blind, placebo-controlled, multicentre trial

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal 17

Infection Response to SARS-CoV-2

A pneumonia outbreak associated with a new coronavirus of probable 19 bat origin

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated

J o u r n a l P r e -p r o o f Highlights: • Human alveospheres are composed of renewing AT2 cells and AT1-like cells • Alveolar epithelial cells are efficiently infected by SARS-CoV-2 in vitro • Interferon signaling is activated in SARS-CoV-2 infected alveolar epithelial cells • Lung organoid models provide a platform for drug discovery and disease modeling

In vitro models of human lung epithelium including diverse cell types of proximo-distal axis are critical for modeling infection. Mulay et al. show that alveospheres, with epithelial type 2 and type 1-like cells, are infected by SARS-CoV-2, initiating an interferon response and serve as a platform for screening antiviral drugs.